Matteo Lambertini

16.9k total citations · 5 hit papers
330 papers, 7.3k citations indexed

About

Matteo Lambertini is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Cancer Research. According to data from OpenAlex, Matteo Lambertini has authored 330 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Oncology, 101 papers in Public Health, Environmental and Occupational Health and 88 papers in Cancer Research. Recurrent topics in Matteo Lambertini's work include Reproductive Biology and Fertility (91 papers), Breast Cancer Treatment Studies (78 papers) and Cancer Risks and Factors (77 papers). Matteo Lambertini is often cited by papers focused on Reproductive Biology and Fertility (91 papers), Breast Cancer Treatment Studies (78 papers) and Cancer Risks and Factors (77 papers). Matteo Lambertini collaborates with scholars based in Italy, Belgium and United States. Matteo Lambertini's co-authors include Lucia Del Mastro, Evandro de Azambuja, Fedro A. Peccatori, Francesca Poggio, Isabelle Demeestere, Noam Pondé, Marcello Ceppi, P. Pronzato, Marco Bruzzone and Hatem A. Azim and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Matteo Lambertini

308 papers receiving 7.2k citations

Hit Papers

ESHRE guideline: female fertility preservation† 2018 2026 2020 2023 2020 2018 2020 2021 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ESHRE guideline: female fertility preservation†
    2020 406 citations Richard A. Anderson, Isabelle Demeestere et al. profile →
  2. Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
    2018 303 citations Francesca Poggio, Marco Bruzzone et al. profile →
  3. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†
    2020 281 citations Matteo Lambertini, Fedro A. Peccatori et al. profile →
  4. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
    2021 168 citations Maria Alice Franzoi, Elisa Agostinetto et al. profile →
  5. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline
    2022 98 citations Judith Balmañà, Giuseppe Curigliano et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matteo Lambertini Italy 46 4.1k 2.6k 1.9k 1.3k 1.1k 330 7.3k
Fedro A. Peccatori Italy 49 4.7k 1.2× 2.8k 1.1× 2.1k 1.1× 1.4k 1.0× 901 0.8× 260 8.7k
Lucia Del Mastro Italy 48 5.3k 1.3× 1.8k 0.7× 1.3k 0.7× 2.5k 1.8× 1.6k 1.4× 332 8.7k
Paul Sabbatini United States 45 4.0k 1.0× 928 0.4× 2.5k 1.3× 658 0.5× 703 0.6× 182 8.8k
Rosemary D. Cress United States 38 3.9k 1.0× 747 0.3× 935 0.5× 1.4k 1.0× 591 0.5× 128 6.9k
Edward E. Partridge United States 49 2.8k 0.7× 1.1k 0.4× 3.8k 1.9× 713 0.5× 689 0.6× 195 9.9k
Edward L. Trimble United States 42 2.6k 0.6× 1.3k 0.5× 4.1k 2.1× 744 0.6× 490 0.4× 135 8.9k
Laura J. Havrilesky United States 47 2.1k 0.5× 809 0.3× 3.5k 1.8× 755 0.6× 707 0.6× 301 8.0k
Barbara A. Goff United States 57 2.4k 0.6× 986 0.4× 5.4k 2.8× 904 0.7× 1.1k 1.0× 231 10.2k
Cristiana Sessa Switzerland 48 3.4k 0.8× 809 0.3× 2.4k 1.2× 1.1k 0.8× 645 0.6× 246 9.1k
Thomas J. Herzog United States 64 3.2k 0.8× 811 0.3× 6.2k 3.2× 1.4k 1.0× 646 0.6× 334 13.3k

Countries citing papers authored by Matteo Lambertini

Since Specialization
Citations

This map shows the geographic impact of Matteo Lambertini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Lambertini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Lambertini more than expected).

Fields of papers citing papers by Matteo Lambertini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Lambertini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Lambertini. The network helps show where Matteo Lambertini may publish in the future.

Co-authorship network of co-authors of Matteo Lambertini

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Lambertini. A scholar is included among the top collaborators of Matteo Lambertini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Lambertini. Matteo Lambertini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spinaci, Stefano, et al.. (2025). Treatments of Interest in Male Breast Cancer: An Umbrella Review. Journal of Personalized Medicine. 15(2). 66–66. 1 indexed citations
2.
Matos, Leonor Vasconcelos de, Elisa Agostinetto, Matteo Lambertini, et al.. (2025). Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives. The Breast. 84. 104558–104558.
3.
Blondeaux, Eva, Francesca Poggio, Alessandra Fabi, et al.. (2025). Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world. ESMO Open. 10(2). 104125–104125. 1 indexed citations
4.
Lambertini, Matteo, et al.. (2025). Efficacy of goserelin in ovarian function suppression and preservation for pre- and perimenopausal breast cancer patients: a systematic review. Therapeutic Advances in Medical Oncology. 17. 22764432–22764432. 2 indexed citations
5.
Heidinger, Martin, Ricardo Coelho, Fabienne D. Schwab, et al.. (2025). TP53 Mutations and Phosphatidylinositol 3-Kinase/AKT Pathway Alterations Are Key Determinants of Breast Cancer Outcome Independent of Subtype and Stage. JCO Precision Oncology. 9(9). e2400767–e2400767.
6.
Lambertini, Matteo, Pietro De Placido, Sabino De Placido, et al.. (2024). Abstract PO4-03-07: The impact of chemotherapy relative dose intensity on pathological complete response in patients with triple negative breast cancer treated with neoadjuvant chemotherapy. Cancer Research. 84(9_Supplement). PO4–3. 1 indexed citations
7.
Lambertini, Matteo, Eva Blondeaux, Elisa Agostinetto, et al.. (2024). Clinical behavior of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing: Results from an international cohort study.. Journal of Clinical Oncology. 42(16_suppl). 10503–10503. 1 indexed citations
8.
Tagliamento, Marco, et al.. (2024). Tackling Non–Small Cell Lung Cancer in Young Adults: From Risk Factors and Genetic Susceptibility to Lung Cancer Profile and Outcomes. American Society of Clinical Oncology Educational Book. 44(3). e432488–e432488. 9 indexed citations
9.
Agostinetto, Elisa, Matteo Lambertini, Françoise Rothé, et al.. (2022). Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse. JCO Precision Oncology. 6(6). e2200148–e2200148. 48 indexed citations
10.
Mair, Maximilian J., Elizabeth A. Connolly, Maria Kfoury, et al.. (2022). Career and Professional Development for Young Oncologists. Oncology Research and Treatment. 46(3). 67–71. 2 indexed citations
11.
Anderson, Richard A., et al.. (2022). Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer. Breast Cancer Research and Treatment. 192(2). 273–282. 10 indexed citations
12.
Anderson, Richard A., David Cameron, Florian Clatot, et al.. (2022). Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review. Human Reproduction Update. 28(3). 417–434. 61 indexed citations
13.
Turan, Volkan, Matteo Lambertini, Dong‐Yun Lee, et al.. (2021). Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data. Journal of Clinical Oncology. 39(18). 2016–2024. 41 indexed citations
14.
Poorvu, Philip D., Jiani Hu, Yue Zheng, et al.. (2021). Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer. npj Breast Cancer. 7(1). 99–99. 19 indexed citations
15.
Tagliamento, Marco, Elisa Agostinetto, Roberto Borea, et al.. (2021). VISTA: A Promising Target for Cancer Immunotherapy?. SHILAP Revista de lepidopterología. Volume 10. 185–200. 41 indexed citations
16.
Tagliamento, Marco, Elisa Agostinetto, Marco Bruzzone, et al.. (2021). Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 163. 103365–103365. 44 indexed citations
17.
Parisi, Francesca, Maria Grazia Razeti, Eva Blondeaux, et al.. (2020). Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer. Clinical Medicine Insights Oncology. 14. 2282627560–2282627560. 6 indexed citations
18.
Poggio, Francesca, Marco Tagliamento, Davide Soldato, et al.. (2020). Update on the Management of Breast Cancer during Pregnancy. Cancers. 12(12). 3616–3616. 38 indexed citations
19.
Saini, Kamal S., Marco Tagliamento, Matteo Lambertini, et al.. (2020). Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. European Journal of Cancer. 139. 43–50. 206 indexed citations
20.
Lambertini, Matteo. (1998). Cross-border trips by Canadians and Americans and the differential impact of the border.. ScholarWorks@BGSU (Bowling Green State University). 17(3). 46–63. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fedro A. Peccatori Breakdown of academic impact, for papers by Lucia Del Mastro Breakdown of academic impact, for papers by Paul Sabbatini Breakdown of academic impact, for papers by Rosemary D. Cress Breakdown of academic impact, for papers by Edward E. Partridge Breakdown of academic impact, for papers by Edward L. Trimble Breakdown of academic impact, for papers by Laura J. Havrilesky Breakdown of academic impact, for papers by Barbara A. Goff Breakdown of academic impact, for papers by Cristiana Sessa Breakdown of academic impact, for papers by Thomas J. Herzog
Rankless by CCL
2026